A clinical conundrum: clozapine and COVID-19.

Naguy, Ahmed; Moodliar-Rensburg, Seshni; Alamiri, Bibi

Naguy, Ahmed; Moodliar-Rensburg, Seshni; Alamiri, Bibi.

Naguy A; Kuwait City, Kuwait.
Moodliar-Rensburg S; Buckinghamshire, UK.
Alamiri B; Medford, USA.

Australas Psychiatry ; 29(5): 559-560, 2021 10.

Article in English | MEDLINE | ID: covidwho-1099854

Subject(s)

Antipsychotic Agents; COVID-19; Clozapine; Schizophrenia; Antipsychotic Agents/adverse effects; Clozapine/adverse effects; Humans; SARS-CoV-2; Schizophrenia/drug therapy

Keywords

COVID-19; Clozapine; schizophrenia

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Schizophrenia / Antipsychotic Agents / Clozapine / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: Australas Psychiatry Journal subject: Psychiatry Year: 2021 Document Type: Article Affiliation country: 1039856221992647

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google